Carregant...
Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies
SIMPLE SUMMARY: Although conventional anti-cancer drugs have been the footstone in the fight against cancer, yet they are far from optimal due to issues related with indiscriminate destruction of normal cells, multidrug resistance, and toxicity, as a result, a more selective therapy is urgently need...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7600685/ https://ncbi.nlm.nih.gov/pubmed/32998391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102783 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|